POST Online Media Lite Edition


NEWLY REPORTED COVID-19 CASES (latest WHO data):   U.S. 133,475    India 18,711    Brazil 75,495    Russia 11,022    The United Kingdom 5,946    France 22,725    Italy 24,010    Turkey 11,302    Germany 9,557    Columbia 3,371    Argentina 4,860    Mexico 6,797    Iran 8,212    South Africa 1,313    Ukraine 9,144    Indonesia 5,767    Peru 8,447    Czechia 13,162    The Netherlands 4,727    Canada 3,370    Chile 5,033    Romania 4,342    Portugal 1,489    Iraq 4,068    Sweden 4,811    Philippines 3,434    Pakistan 1,714    Serbia 4,071    Austria 2,319    Hungary 7,269    Japan 1,064    Jordan 3,481    United Arab Emirates 2,959    Lebanon 3,158    Slovakia 2,522    Malaysia 1,680    Belarus 1,480    Ecuador 1,873    Bulgaria 3,004    Palestine 2,011    Greece 2,181    Kuwait 1,318    Moldova 1,788    Guatemala 1,461    Paraguay 1,501    Ethiopia 1,118    Estonia 1,540    China 28    Singapore 13    New Zealand 1    Australia 10    South Korea 416   

U.S. connecting supercomputers produce vaccine against coronavirus

Christian Fernsby |
The United States has combined the power of supercomputers to produce a vaccine against coronavirus through public-private partnerships,” the U.S. Department of Energy said in a press release.

Article continues below


"Launching a consortium of high-performance computers against COVID-19 will provide Corona virus researchers with access to the world's most powerful computing resources, which could accelerate the discovery of scientific discoveries in the fight against the virus," the ministry said.

In addition to the Department of Energy and the White House, IBM has been a co-founder of the consortium.

The ministry also said: "The consortium is currently uniting 16 systems that offer computing potential at levels above 330 Flops."

President Donald Trump thanked Google, Microsoft and Amazon, as well as the Massachusetts Institute of Technology and NASA for joining the consortium.

What to read next

3-in-1 vaccine against traveler's diarrhea
Candidate Ebola vaccine still effective when highly diluted
Zika vaccine works in early human trial